Across TCGA pan-cancer cohorts, RNU6-867P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RNU6-867P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNU6-867P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-867P expression acts as an unfavorable survival marker.

BRCA are the cancer types where RNU6-867P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.844	0.963	.040	18	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: RNU6-867P tumor-vs-normal RNA expression · all RNU6-867P data types